NSCLC therapy
BY
Developing a smart innovative inhalable nanosystem for treatment of non-small cell lung cancer
How We Help
Company Info
Clinical & IP
Clinical Validation
<p>Our specific intended complexes did not entered clinical steps, yet as for the efficacy of our nanocarrier and drug there are clinical evidences in the literature. In fact, there are some pre-clinical and clinical research works about enhanced efficiency of cyclodextrin loaded with resveratrol in comparison with basic resveratrol. The research, suggested the increased antiviral, antitumor, antioxidant and anti-inflammatory properties of resveratrol.</p>
Only accessible to MedStartr community members.
Join nowWhat do you think of NSCLC therapy?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Comments
Comments from new members are shown once the company's team has approved them. Please follow the community rules.
Sign in to join the conversation.
Sign in to comment